Evidence map›Paper›PMID 40036355›Full record

ArticleThe Journal of infectious diseases2025

Invasive Group B Streptococcal Disease Among Nonpregnant Adults: Alaska, 2004-2023.

Victoria A Balta, Sara Bressler, Stephanie Massay, Laurie Orell, Alisa Reasonover, Marcella Harker-Jones, Tony Kretz, Marc Fischer, Joseph McLaughlin, Jonathan Steinberg

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. A murine model of adult gastrointestinal colonization by Group BbioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Victoria A BaltaArctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.ORCID 0000-0003-0685-6697
Sara BresslerArctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.
Stephanie MassaySection of Epidemiology, Division of Public Health, Alaska Department of Health, Anchorage, Alaska, USA.
Laurie OrellArctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.ORCID 0000-0003-3608-5854
Alisa ReasonoverArctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.
Marcella Harker-JonesArctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.
Tony KretzArctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.
Marc FischerArctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.
Joseph McLaughlinSection of Epidemiology, Division of Public Health, Alaska Department of Health, Anchorage, Alaska, USA.
Jonathan SteinbergArctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.ORCID 0000-0001-8446-5304

Funding

CDC HHSIntramural CDC HHS CC999999
6 · The paper itself

Abstract

We describe the epidemiology of invasive group B streptococcal (GBS) disease among nonpregnant Alaska adults using statewide surveillance data. During 2004-2023, 880 cases of invasive GBS disease were reported for an age-adjusted annual incidence of 9.1 (95% confidence interval [CI], 8.5-9.7) cases per 100 000 adults. Incidence increased 1.9-fold (95% CI, 1.6-2.2) between 2004-2013 and 2014-2023. Adults aged ≥65 years had a 4.4-fold higher risk of invasive disease compared to younger adults, and 47% of adults with invasive GBS had diabetes. Health care providers should be aware of populations at increased risk, potentially allowing for more prompt treatment.

Indexed as

Streptococcal InfectionsStreptococcus agalactiaeAdultAgedAged, 80 and overAge FactorsAlaskaDiabetes MellitusFemaleHumansIncidenceMaleMiddle AgedRisk FactorsYoung AdultadultAlaskaincidencepublic healthStreptococcus agalactiaesurveillance

Identifiers

PMID40036355
PMCPMC12353656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.